Year
2025
Organisation
Summary
This research uses artificial intelligence to design therapeutic molecules targeting platelet protein mutations in bleeding disorders. A lead molecule disrupts pathological clot formation, demonstrates high binding affinity, and restores function in patient-derived samples. The work advances both treatment and diagnostic development, representing a promising step toward precision medicine for coagulation-related diseases.